RxDoctor Payments Data

Diane Nelson, OD

Optometrist · Derry, NHNPI 1861579070

Payments from drug & device makers

What this record shows

10 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 55.6% of the total. Reporting peaked in 2019 at $1,499 and has fallen 82.9% since, to $256 in 2025.

$2,648in general payments, 2019–2025

Across 46 payments — averaging $57.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$1K
  • Coopervision Inc.$492
  • Bausch & Lomb Americas Inc.$222
  • Alcon$220
  • Oyster Point Pharma, Inc.$124
  • Johnson & Johnson Vision Care, Inc.$42
  • plus $74 from 4 others

What the payments were for

  • Travel & lodging$1,47356%
  • Food & beverage$1,17544%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,648 in reported general payments places this provider in the 85th percentile of 235 optometrist providers in New Hampshire.

See all optometrist providers in New Hampshire

Medicare billing

Part B allowed, 2024
$39,893
Medicare patients
190
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost20$8,380
Latanoprost130$803
Timolol Maleate38$139

Paid to pharmacies, not to this prescriber.

Other optometrist in Derry

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →